- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
|International Nonproprietary Names|
|Solanezumab is an investigational humanized monoclonal antibody targeting amyloid-β (Aβ).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. The invention of solanezumab is covered by patent US7195761 , where it is coded as Hu266.
|GtoPdb PubChem SID||178103514|
|Search PubMed clinical trials||solanezumab|
|Search PubMed titles||solanezumab|
|Search PubMed titles/abstracts||solanezumab|